Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei

Phytomedicine

Volumn 17, Issue 2, 2010, Pages 139-141

  Yang, Zaichang ^a   Niu, Yule ^a   Le, Yi ^a   Ma, Xiaoyan ^a   Qiao, Chong ^a  

^a GUIZHOU UNIVERSITY   (China)

Author keywords

Beta lactamase inhibitor; Bioassay guided isolation; Fissistigma cavaleriei

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CLAVULANIC ACID; FISSISTIGMA CAVALERIEI EXTRACT; PLANT EXTRACT; SALSALATE; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; DOSE RESPONSE; FISSISTIGMA CAVALERIEI; INHIBITION KINETICS; ISOLATION PROCEDURE; NONHUMAN; PLANT; PLANT ROOT; PRIORITY JOURNAL; SPECTROSCOPY;

ANNONACEAE; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-LACTAMASES; CLAVULANIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ENZYME INHIBITORS; INHIBITORY CONCENTRATION 50; PLANT EXTRACTS; PLANT ROOTS; PSEUDOMONAS AERUGINOSA; SALICYLIC ACIDS;

FISSISTIGMA;

EID: 73449103157     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.08.003     Document Type: Article

References (15)

1. Bao J., and Ran M.X. The Studies and Development of Miao Peoples Medicine in Guizhou Province (1987), Guizhou Science and Technology Press, Guiyang, China pp. 189-192
2. Cantu III C., Huang W., and Palzkill T. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime. J. Biol. Chem. 271 (1996) 22538-22545
3. Chaibi E.B., Sirot D., Paul G., and Labia R. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43 (1999) 447-458
4. Coates N.J., Gilpin M.L., Gwynn M.N., Lewis D.E., Milner P.H., Spear S.R., and Tyler J.W. SB-202742, a novel beta-lactamase inhibitor isolated from Spondias mombin. J. Nat. Prod. 57 (1994) 654-657
5. Estes D., and Kaplan K. Lack of platelet effect with the aspirin analog, salsalate. Arthritis Rheum. 23 (1980) 1303-1307
6. Hemaiswarya S., Kruthiventi A.K., and Doble M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 15 (2008) 639-652
7. Huang W.Z., Beharry Z., Zhang Z., and Palzkill T. A broad-spectrum peptide inhibitor of beta-lactamase identified using phage display and peptide arrays. Protein Eng. 16 (2003) 853-860
8. Lee N., Yuen K.-Y., and Kumana C. Clinical role of beta-lactam/beta-lactamase inhibitor combinations. Drugs 63 (2003) 1511-1524
9. Merck Research Laboratories. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase. J. Biol. Chem. 276 (2001) 31913-31918
10. Miller L.A., Ratnam K., and Payne D.J. Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments. Curr. Opin. Pharmacol. 1 (2001) 451-458
11. Ramos J.J.M., Diogo H.P., Godinho M.H., and Cruz C. Anomalous thermal behavior of salicylsalicylic acid and evidence for a monotropic transition to a nematic phase. J. Phys. Chem. B 108 (2004) 7955-7962
12. Tondi D., Morandi F., Bonnet R., Costi M.P., and Shoichet B.K. Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture. J. Am. Chem. Soc. 127 (2005) 4632-4639
13. Tunér K., Lindqvist L., and Nord C.E. Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob. Agents Chemother. 27 (1985) 943-947
14. Wagner H., and Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16 (2009) 97-110
15. Zhao W.-H., Hu Z.-Q., Hara Y., and Shimamura T. Inhibition of penicillinase by epigallocatechin-gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob. Agents Chemother. 46 (2002) 2266-2268